Skip to main content
OpenTrials

Clinical trial condition

NSCLC (Advanced Non-small Cell Lung Cancer)

Explore clinical trials studying NSCLC (Advanced Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.

52 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

NSCLC (Advanced Non-small Cell Lung Cancer) trial results

Recruiting

Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC

NCT07158489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonsspital Baden Baden, Switzerland
  • Universitätsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
  • Kantonsspital Graubuenden Chur, Switzerland
View Trial Details
Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

NCT07705334

Conditions
Adenoma, Advanced or Metastatic Solid Tumors, Breast Diseases, +40 more
Locations
  • SCRI at HCA HealthONE Denver, Colorado, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 152 locations
View Trial Details
Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

NCT06706076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Arizona Phoenix, Arizona, United States
  • The Regents of the University of California - Irvine, CA Campus Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 42 locations
View Trial Details
Recruiting

Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

NCT07001618

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Georges François Leclerc Dijon, France
  • CHU Grenoble Grenoble, France
  • Hôpital Bichat - Claude Bernard Paris, France
  • Hôpital Foch Suresnes, France
View Trial Details

Related conditions